XML 73 R63.htm IDEA: XBRL DOCUMENT v3.24.2.u1
FAIR VALUE DISCLOSURES - Narrative (Details) - USD ($)
6 Months Ended
Feb. 22, 2024
Dec. 12, 2023
Jun. 30, 2024
Jun. 30, 2023
Jun. 28, 2024
Jan. 24, 2024
Dec. 31, 2023
Fair Value Measurement Inputs and Valuation Techniques [Line Items]              
Money market funds     $ 166,485,000       $ 191,841,000
Interest rate swap     $ 7,366,000       6,236,000
Achievement of milestones payment period     24 months        
Payments on contingent consideration     $ 12,500,000 $ 0      
Contingent consideration     11,900,000       24,000,000.0
CG Oncology              
Fair Value Measurement Inputs and Valuation Techniques [Line Items]              
Shares held (in shares)           219,925  
Value of shares held     6,900,000        
Closing price         $ 31.57    
Novitium              
Fair Value Measurement Inputs and Valuation Techniques [Line Items]              
Additional contingent consideration     46,500,000        
Payments on contingent consideration $ 12,500,000 $ 12,500,000          
Contingent consideration     $ 11,933,000       $ 23,984,000